- Remimazolam in pediatric surgery under general anesthesia: a case series
-
Hong-Sik Shon, Seyeon Park, Jung-Pil Yoon, Yeong Min Yoo, Jimin Lee, Da Eun Lee, Hee Young Kim
-
Kosin Med J. 2024;39(3):201-206. Published online May 9, 2024
-
DOI: https://doi.org/10.7180/kmj.24.105
-
-
1,568
View
-
43
Download
-
1
Citations
-
 Abstract
 PDF PubReader  ePub
- Remimazolam is a promising drug for general anesthesia due to its rapid onset, short duration, and short context-sensitive half-life. However, its use in pediatric patients remains off-label, and limited prospective data have been published. Herein, we report successful anesthesia using remimazolam in pediatric patients who had a history of epilepsy or required shared airway surgery. In all cases, remimazolam provided general anesthesia, and flumazenil was used for reversal with rapid recovery. Remimazolam offers advantages for pediatric anesthesia in scenarios with a risk of seizure or shared airway surgery. However, the potential for higher bispectral index values and the risk of anaphylaxis in dextran-allergic patients necessitate caution and further research.
-
Citations
Citations to this article as recorded by  - Remimazolam: Is the new “wonder drug” in anesthesia any good in children?
Tom G. Hansen, Thomas Engelhardt
Acta Anaesthesiologica Scandinavica.2025;[Epub] CrossRef
|
KOSIN UNIVERSITY COLLEGE OF MEDICINE
